Cargando…
Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
Much hope in drug development comes from the discovery of positive allosteric modulators (PAM) that display target subtype selectivity and act by increasing agonist potency and efficacy. How such compounds can allosterically influence agonist action remains unclear. Metabotropic glutamate receptors...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440590/ https://www.ncbi.nlm.nih.gov/pubmed/34521824 http://dx.doi.org/10.1038/s41467-021-25620-5 |
_version_ | 1783752708375707648 |
---|---|
author | Cao, Anne-Marinette Quast, Robert B. Fatemi, Fataneh Rondard, Philippe Pin, Jean-Philippe Margeat, Emmanuel |
author_facet | Cao, Anne-Marinette Quast, Robert B. Fatemi, Fataneh Rondard, Philippe Pin, Jean-Philippe Margeat, Emmanuel |
author_sort | Cao, Anne-Marinette |
collection | PubMed |
description | Much hope in drug development comes from the discovery of positive allosteric modulators (PAM) that display target subtype selectivity and act by increasing agonist potency and efficacy. How such compounds can allosterically influence agonist action remains unclear. Metabotropic glutamate receptors (mGlu) are G protein-coupled receptors that represent promising targets for brain diseases, and for which PAMs acting in the transmembrane domain have been developed. Here, we explore the effect of a PAM on the structural dynamics of mGlu2 in optimized detergent micelles using single molecule FRET at submillisecond timescales. We show that glutamate only partially stabilizes the extracellular domains in the active state. Full activation is only observed in the presence of a PAM or the G(i) protein. Our results provide important insights on the role of allosteric modulators in mGlu activation, by stabilizing the active state of a receptor that is otherwise rapidly oscillating between active and inactive states. |
format | Online Article Text |
id | pubmed-8440590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84405902021-10-04 Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state Cao, Anne-Marinette Quast, Robert B. Fatemi, Fataneh Rondard, Philippe Pin, Jean-Philippe Margeat, Emmanuel Nat Commun Article Much hope in drug development comes from the discovery of positive allosteric modulators (PAM) that display target subtype selectivity and act by increasing agonist potency and efficacy. How such compounds can allosterically influence agonist action remains unclear. Metabotropic glutamate receptors (mGlu) are G protein-coupled receptors that represent promising targets for brain diseases, and for which PAMs acting in the transmembrane domain have been developed. Here, we explore the effect of a PAM on the structural dynamics of mGlu2 in optimized detergent micelles using single molecule FRET at submillisecond timescales. We show that glutamate only partially stabilizes the extracellular domains in the active state. Full activation is only observed in the presence of a PAM or the G(i) protein. Our results provide important insights on the role of allosteric modulators in mGlu activation, by stabilizing the active state of a receptor that is otherwise rapidly oscillating between active and inactive states. Nature Publishing Group UK 2021-09-14 /pmc/articles/PMC8440590/ /pubmed/34521824 http://dx.doi.org/10.1038/s41467-021-25620-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Cao, Anne-Marinette Quast, Robert B. Fatemi, Fataneh Rondard, Philippe Pin, Jean-Philippe Margeat, Emmanuel Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state |
title | Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state |
title_full | Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state |
title_fullStr | Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state |
title_full_unstemmed | Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state |
title_short | Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state |
title_sort | allosteric modulators enhance agonist efficacy by increasing the residence time of a gpcr in the active state |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440590/ https://www.ncbi.nlm.nih.gov/pubmed/34521824 http://dx.doi.org/10.1038/s41467-021-25620-5 |
work_keys_str_mv | AT caoannemarinette allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate AT quastrobertb allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate AT fatemifataneh allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate AT rondardphilippe allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate AT pinjeanphilippe allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate AT margeatemmanuel allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate |